(Q34512948)

2 August 2017

1 reference

title

Heredity and genetic aspects of Raynaud's disease (English)

1 reference

2 August 2017

Pistorius MA

1

1 reference

2 August 2017

Planchon B

series ordinal

2

1 reference

2 August 2017

Schott JJ

series ordinal

3

1 reference

2 August 2017

Lemarec H

series ordinal

4

1 reference

2 August 2017

publication date

1 February 2006

1 reference

Journal des maladies vasculaires

2 August 2017

published in

1 reference

2 August 2017

volume

31

1 reference

2 August 2017

issue

1

1 reference

2 August 2017

page(s)

10-15

1 reference

Familial Raynaud's phenomenon and localized scleroderma associated with essential telangiectasia and cytogenetic abnormalities

2 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0398-0499%2806%2976512-X

7 January 2021

Primary Raynaud's phenomenon in monozygotic twins

1 reference

https://api.crossref.org/works/10.1016%2FS0398-0499%2806%2976512-X

7 January 2021

Genetic factors in the etiology of systemic sclerosis and Raynaud phenomenon

1 reference

https://api.crossref.org/works/10.1016%2FS0398-0499%2806%2976512-X

7 January 2021

Clinical practice. Raynaud's Phenomenon

1 reference

https://api.crossref.org/works/10.1016%2FS0398-0499%2806%2976512-X

7 January 2021

Raynaud's phenomenon in a female population: prevalence and association with other conditions

1 reference

https://api.crossref.org/works/10.1016%2FS0398-0499%2806%2976512-X

7 January 2021

Familial aggregation of primary Raynaud's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0398-0499%2806%2976512-X

7 January 2021

A case-control study of candidate vasoactive mediator genes in primary Raynaud's phenomenon

1 reference

https://api.crossref.org/works/10.1016%2FS0398-0499%2806%2976512-X

7 January 2021

Primary Raynaud's phenomenon. Age of onset and pathogenesis in a prospective study of 424 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0398-0499%2806%2976512-X

7 January 2021

A common genetic factor underlies hypertension and other cardiovascular disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0398-0499%2806%2976512-X

7 January 2021

A new autosomal dominant vascular retinopathy syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS0398-0499%2806%2976512-X

7 January 2021

Clinical and genetic analysis of a large Dutch family with autosomal dominant vascular retinopathy, migraine and Raynaud's phenomenon

1 reference

https://api.crossref.org/works/10.1016%2FS0398-0499%2806%2976512-X

7 January 2021

Hereditary vascular retinopathy, cerebroretinal vasculopathy, and hereditary endotheliopathy with retinopathy, nephropathy, and stroke map to a single locus on chromosome 3p21.1-p21.3

1 reference

https://api.crossref.org/works/10.1016%2FS0398-0499%2806%2976512-X

7 January 2021

Deficiency of calcitonin gene-related peptide in Raynaud's phenomenon

1 reference

https://api.crossref.org/works/10.1016%2FS0398-0499%2806%2976512-X

7 January 2021

Raynaud's phenomenon, calcitonin gene-related peptide, endothelin, and cutaneous vasculature

1 reference

https://api.crossref.org/works/10.1016%2FS0398-0499%2806%2976512-X

7 January 2021

Raynaud's phenomenon: state of the art 1998.

1 reference

https://api.crossref.org/works/10.1016%2FS0398-0499%2806%2976512-X

7 January 2021

Plasma nitric oxide metabolite in women with primary Raynaud's phenomenon and in healthy subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0398-0499%2806%2976512-X

7 January 2021

Treatment of Raynaud's phenomenon with the selective serotonin reuptake inhibitor fluoxetine

1 reference

https://api.crossref.org/works/10.1016%2FS0398-0499%2806%2976512-X

7 January 2021

Serotoninergic status in patients with hereditary vascular retinopathy syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0398-0499%2806%2976512-X

7 January 2021

Acquired factor VIII deficiency and polyradiculoneuropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0398-0499%2806%2976512-X

7 January 2021

Abnormal platelet aggregation in patients with Raynaud's phenomenon

1 reference

https://api.crossref.org/works/10.1016%2FS0398-0499%2806%2976512-X

7 January 2021

The aetiology of Raynaud's phenomenon

1 reference

https://api.crossref.org/works/10.1016%2FS0398-0499%2806%2976512-X

7 January 2021

Vasomotor instability in neonates with chromosome 22q11 deletion syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0398-0499%2806%2976512-X

7 January 2021

A comprehensive genetic map of the human genome based on 5,264 microsatellites

1 reference

https://api.crossref.org/works/10.1016%2FS0398-0499%2806%2976512-X

7 January 2021

A two-stage, genome-wide screen for susceptibility loci in primary Raynaud's phenomenon

1 reference

https://api.crossref.org/works/10.1016%2FS0398-0499%2806%2976512-X

7 January 2021

Increased prevalence of migraine and chest pain in patients with primary Raynaud disease

1 reference

https://api.crossref.org/works/10.1016%2FS0398-0499%2806%2976512-X

7 January 2021

Prevalence of Raynaud's phenomenon in a healthy Greek population

1 reference

https://api.crossref.org/works/10.1016%2FS0398-0499%2806%2976512-X

7 January 2021

Prevalence of Raynaud's phenomenon in patients with migraine

1 reference

https://api.crossref.org/works/10.1016%2FS0398-0499%2806%2976512-X

7 January 2021

10.1016/S0398-0499(06)76512-X

Identifiers

DOI

1 reference

2 August 2017

1 reference